Use this form to add your product announcement, press release, case study or white paper to our web site.
Please Note: All submitted content is subject to approval before it will appear on the live web site.
Please make sure to include your contact information at the bottom of your post in case we need to contact you in regards to your submission.
Test- AI Drug Repurposing Tool Offers Suggestions Based on Disease NetworksClinical Research News | arvard scientists, led by Dr. Marinka Zitnik, have developed an AI-based tool, TxGNN, to identify drug repurposing opportunities for diseases lacking effective treatments. The AI model harnesses a novel approach by focusing on multiple diseases simultaneously, allowing insights from well-documented conditions to be applied to rare diseases with sparse data.
- Pharma Leaders Tackle Persistent Quality Challenges and the Future of Clinical TrialsClinical Research News | Pharma leaders took on clinical trial quality in a panel discussion at the SCOPE Europe conference last month in Barcelona. While technologies change, the conversation underscored a central truth: the push for quality in clinical research remains as vital, yet as challenging, as ever.
- The Case for Integrating Placental Pathology into Prospective Clinical TrialsClinical Research News | Perinatal pathologists are calling for placental pathology to be incorporated into prospective clinical trials so they can start telling clinical providers what the findings in their reports mean. For want of funding and the relevant diagnostic expertise, the placenta has long been a woefully under-investigated organ that could be providing critical […]
- AI Regulation Sparks Debate at Scope Europe Conference: Industry Leaders Weigh InClinical Research News | Last week at SCOPE Europe, industry leaders took on the impact of AI regulation—particularly the European Union's AI Act—on the clinical research and life sciences sectors. Moderated by BioSpace’s Lori Ellis, the panelists included Firas Abdessalem of Sanofi, Christopher Hart of Foley Hoag, Ricardo Gaminha Pacheco of InSilico Medicine, and Artemy […]
- Ensuring Study Participant Adherence: Strategies for Successful Remote Data Collection in Clinical Trials Using Wearable TechnologiesClinical Research News | Ensuring clinical trial participants adhere to study protocols is essential for reliable clinical trial results. If participants aren't consistent with their participation, the data collected won't accurately reflect the effectiveness of a treatment or therapy. Poor adherence can slow down or even derail clinical breakthroughs.
- Scope of Things: SCOPE Europe 2024, AI in Clinical Trials, Rising Stars, MoreClinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz gives you the latest news on a study for AI system for drug repurposing, a window trial for a new triple-negative breast cancer treatment, Jill Pellegrino’s transition from CVS to AutoCruitment, publication bias with industry sponsored studies for psychiatric […]
- What Will It Take—And What Does It Look Like—For Clinical Care and Clinical Research To Converge?Clinical Research News | A profound shift is underway: one that positions patients not merely as recipients of clinical care but as active participants and collaborators in clinical research. A panel at last week’s SCOPE Summit Europe took on this challenge.
- SCOPE Europe 2024 Announces Best of Show WinnersClinical Research News | Clinical Research News and ClinEco announced three Best of Show winners today at the 2024 SCOPE Europe conference in Barcelona, Spain. The winning companies that submitted their products include Anju Software, Greenphire, and Medidata.
- IQVIA Introduces New AI Assistant, DHL Express, Thermo Fisher Partnership, Novel Cellular Blood Pressure Monitor, MoreClinical Research News | IQVIA introduces IQVIA AI Assistant; DHL Express and Thermo Fisher Scientific join forces to drive more sustainable clinical research services; Withings Health Solutions announces a first-of-its-kind cellular blood pressure monitor; and more.
- Follow the Money: Trials for Major Depressive Disorder Therapies, Kidney Disease Treatment, MoreClinical Research News | Seaport Therapeutics plans to advance their therapeutic candidate SPT-300, an oral prodrug of allopregnanolone; Purespring Therapeutics will initiate a clinical trial for IgAN, a common, chronic kidney disease primarily affecting young adults; and more.
By submitting this form, I authorize I have approval to submit content on behalf on my respective company.
Please email shannong@webcomcommunications.com if you have any questions.
